Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Latest late clinical blogs

Meet our experts at the following events

Conference

2026 SNMMI Annual Meeting

May 30 - June 2, 2026 – Los Angeles, CA
Conference

ASCO Annual Meeting 2026

May 30 - June 2, 2026 – Chicago, IL – Booth #17141
Conference

Marbach DDI Workshop 2026

May 31 - June 2, 2026

All late clinical resources

FDA Rebuilding After DOGE Cuts: Former Regulators Speak Out

New Approach Methodologies (NAMs), Press Coverage

Minimize risk when preparing for hepatic impairment studies

Certara Products - Simcyp, Clinical Pharmacology, Clinical Trials, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Webinar

PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials

Certara Products - Simcyp, Modeling and Simulation - PBPK, Press Coverage

4 Key Principles of Effective Pharmacokinetic Data Reporting

Blog

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Why CROs should use Pinnacle 21 Enterprise for late phase clinical data validation

Certara Products - Pinnacle 21, Blog

Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation – PK/PD, Therapeutic Specialties, Publication

Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation – PK/PD, Therapeutic Specialties, Publication

Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation – PK/PD, Therapeutic Specialties, Publication

The one-trial era: what the FDA’s shift signals for the future of drug development

Certara Products - Simcyp, Certara Services, Press Coverage

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

Certara Products - Certara IQ, Modeling and Simulation, Modeling and Simulation - QSP, Publication

GxP Compliance in the Cloud: What IT Teams Need to Rethink

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.